[Hub]/) : Traits : Basal cell carcinoma (self-reported) : →

chr2:201,308,117-203,035,423

Best TWAS P=2.44e-14 · Best GWAS P=6.29e-14 conditioned to 1

Associated models

#	Study	Tissue	Gene	h2	eQTL R2	model	# weights	model R2	model R2 P	eQTL GWAS Z	TWAS Z	TWAS P	Top SNP corr	PP3	PP4	joint
1	GTEx	Adipose Subcutaneous	CASP8	0.24	0.30	enet	14	0.32	6.6e-27	6.0	-7.3	3.8e-13	-0.87	0.09	0.91	FALSE
2	GTEx	Adipose Subcutaneous	ALS2CR12	0.19	0.11	enet	23	0.15	2.9e-12	7.5	7.3	3.0e-13	0.86	0.00	1.00	FALSE
3	GTEx	Adipose Visceral Omentum	CASP8	0.20	0.16	lasso	7	0.15	2.7e-08	7.3	-7.1	9.6e-13	-0.85	0.01	0.99	FALSE
4	GTEx	Artery Aorta	ALS2CR12	0.23	0.18	enet	19	0.17	7.0e-10	7.5	6.9	6.8e-12	0.88	0.00	1.00	FALSE
5	GTEx	Artery Tibial	CASP8	0.07	0.07	enet	20	0.04	2.1e-04	6.0	-6.1	8.8e-10	-0.65	0.10	0.82	FALSE
6	GTEx	Artery Tibial	ALS2CR12	0.09	0.10	lasso	3	0.09	2.4e-07	6.0	6.3	2.7e-10	0.75	0.12	0.88	FALSE
7	GTEx	Brain Cerebellar Hemisphere	CASP8	0.58	0.50	lasso	3	0.46	1.9e-13	7.1	7.1	9.4e-13	0.90	0.01	0.99	FALSE
8	GTEx	Brain Cerebellum	CASP8	0.44	0.47	enet	7	0.46	4.2e-15	7.2	7.2	8.5e-13	0.89	0.01	0.99	FALSE
9	GTEx	Brain Cerebellum	ALS2CR12	0.28	0.16	enet	25	0.13	1.2e-04	6.0	5.4	5.8e-08	0.76	0.05	0.84	FALSE
10	GTEx	Brain Cortex	ALS2CR12	0.31	0.29	enet	15	0.27	4.2e-08	6.0	5.4	6.5e-08	0.68	0.09	0.88	FALSE
11	GTEx	Brain Frontal Cortex BA9	CASP8	0.13	0.24	lasso	1	0.21	3.1e-06	7.1	7.1	9.2e-13	0.91	0.02	0.93	FALSE
12	GTEx	Brain Frontal Cortex BA9	ALS2CR12	0.26	0.29	enet	8	0.24	5.1e-07	6.0	6.2	4.7e-10	0.77	0.04	0.94	FALSE
13	GTEx	Brain Nucleus accumbens basal ganglia	ALS2CR12	0.15	0.15	lasso	8	0.14	1.6e-04	7.5	7.6	3.0e-14	0.99	0.01	0.97	FALSE
14	GTEx	Brain Putamen basal ganglia	ALS2CR12	0.46	0.44	lasso	2	0.40	1.9e-10	6.0	6.0	1.9e-09	0.71	0.22	0.77	FALSE
15	GTEx	Breast Mammary Tissue	CASP8	0.29	0.18	lasso	6	0.20	2.7e-10	6.0	-7.1	1.1e-12	-0.90	0.01	0.99	FALSE
16	GTEx	Breast Mammary Tissue	ALS2CR12	0.13	0.05	enet	10	0.07	2.3e-04	6.0	6.3	3.4e-10	0.71	0.05	0.90	FALSE
17	GTEx	Breast Mammary Tissue (Male)	ALS2CR12	0.35	0.06	lasso	4	0.03	5.8e-02	6.0	5.9	3.0e-09	0.70	0.04	0.32	FALSE
18	GTEx	Breast Mammary Tissue (Female)	CASP8	0.20	0.24	lasso	4	0.22	3.5e-07	7.5	-7.6	2.4e-14	-1.00	0.00	1.00	TRUE
19	GTEx	Breast Mammary Tissue (Female)	ALS2CR12	0.04	0.03	lasso	5	0.00	2.3e-01	5.6	6.6	3.4e-11	0.78	0.03	0.48	FALSE
20	GTEx	Cells Transformed fibroblasts	CASP8	0.30	0.35	lasso	6	0.35	2.6e-27	6.0	-7.0	2.6e-12	-0.83	0.89	0.11	FALSE
21	GTEx	Cells Transformed fibroblasts	STRADB	0.07	0.02	lasso	4	0.02	1.4e-02	7.5	7.6	3.0e-14	0.97	0.01	0.91	FALSE
22	GTEx	Cells Transformed fibroblasts	CFLAR-AS1	0.07	0.00	enet	14	0.02	2.2e-02	-1.5	5.4	5.5e-08	0.59	0.04	0.69	FALSE
23	GTEx	Colon Sigmoid	ALS2CR12	0.19	0.17	lasso	5	0.15	4.5e-06	6.0	6.1	8.9e-10	0.70	0.06	0.81	FALSE
24	GTEx	Colon Transverse	CASP8	0.21	0.13	lasso	7	0.17	2.1e-08	6.0	-7.3	3.2e-13	-0.89	0.01	0.99	FALSE
25	GTEx	Colon Transverse	ALS2CR12	0.19	0.16	lasso	4	0.14	5.8e-07	6.0	6.2	7.7e-10	0.70	0.17	0.81	FALSE
26	GTEx	Esophagus Gastroesophageal Junction	ALS2CR12	0.13	0.10	lasso	3	0.09	3.0e-04	4.8	6.2	6.7e-10	0.71	0.06	0.91	FALSE
27	GTEx	Esophagus Mucosa	CASP8	0.22	0.17	lasso	6	0.20	4.5e-13	7.3	-6.7	1.7e-11	-0.82	0.01	0.99	FALSE
28	GTEx	Esophagus Mucosa	ALS2CR12	0.09	0.03	lasso	8	0.05	3.7e-04	5.7	6.1	1.1e-09	0.74	0.07	0.92	FALSE
29	GTEx	Esophagus Muscularis	ALS2CR12	0.18	0.10	lasso	7	0.15	2.4e-09	6.0	6.6	3.2e-11	0.79	0.02	0.98	FALSE
30	GTEx	Heart Atrial Appendage	ALS2CR12	0.17	0.15	enet	11	0.12	8.0e-06	6.0	6.2	6.6e-10	0.75	0.04	0.95	FALSE
31	GTEx	Lung	CASP8	0.18	0.18	enet	20	0.18	9.6e-14	6.0	-6.5	8.9e-11	-0.81	0.06	0.94	FALSE
32	GTEx	Muscle Skeletal	CASP8	0.08	0.07	lasso	5	0.07	4.3e-07	6.0	-6.2	7.4e-10	-0.77	0.06	0.94	FALSE
33	GTEx	Muscle Skeletal	ALS2CR12	0.07	0.05	lasso	5	0.03	9.3e-04	4.6	5.3	1.3e-07	0.62	0.05	0.90	FALSE
34	GTEx	Nerve Tibial	ALS2CR12	0.13	0.11	lasso	4	0.08	1.4e-06	6.0	6.0	1.5e-09	0.71	0.10	0.90	FALSE
35	GTEx	Pancreas	CASP8	0.16	0.15	lasso	5	0.13	4.1e-06	7.5	-7.4	9.8e-14	-0.95	0.00	1.00	FALSE
36	GTEx	Skin Not Sun Exposed Suprapubic	CASP8	0.26	0.24	enet	15	0.22	1.8e-12	6.0	-6.3	2.6e-10	-0.72	0.84	0.16	FALSE
37	GTEx	Skin Sun Exposed Lower leg	CASP8	0.24	0.22	enet	12	0.21	2.9e-17	6.0	-6.7	1.8e-11	-0.79	0.62	0.38	FALSE
38	GTEx	Small Intestine Terminal Ileum	ALS2CR12	0.29	0.06	enet	20	0.16	1.8e-04	6.2	5.2	2.1e-07	0.55	0.07	0.37	FALSE
39	GTEx	Spleen	CASP8	0.42	0.39	lasso	3	0.38	1.3e-10	6.0	-6.0	2.7e-09	-0.69	0.56	0.38	FALSE
40	GTEx	Stomach	CASP8	0.18	0.13	lasso	4	0.11	7.3e-06	6.0	-6.2	6.1e-10	-0.71	0.03	0.96	FALSE
41	GTEx	Testis	ALS2CR12	0.28	0.27	enet	11	0.28	9.4e-13	6.0	6.2	4.0e-10	0.77	0.15	0.85	FALSE
42	GTEx	Thyroid	ALS2CR12	0.19	0.12	enet	21	0.15	8.0e-12	6.0	6.5	7.2e-11	0.81	0.01	0.99	FALSE
43	GTEx	Whole Blood	CASP8	0.07	0.04	lasso	8	0.03	1.3e-03	7.1	-6.9	5.4e-12	-0.83	0.02	0.97	FALSE
44	METSIM	Adipose	ALS2CR12	0.08	0.07	lasso	8	0.07	2.5e-11	6.0	5.7	9.4e-09	0.68	0.27	0.73	FALSE
45	METSIM	Adipose	CASP8	0.20	0.20	lasso	12	0.19	1.2e-27	6.0	-6.3	3.1e-10	-0.75	0.89	0.11	FALSE
46	NTR	Blood	CASP8	0.04	0.04	lasso	9	0.04	4.0e-13	6.0	-6.0	2.4e-09	-0.71	0.89	0.11	FALSE
47	ROSMAP	Brain Pre-frontal Cortex	CASP8	0.20	0.20	bslmm	368	0.20	5.5e-25	7.2	7.3	2.4e-13	0.86	0.01	0.99	FALSE
48	The Cancer Genome Atlas	Breast Invasive Carcinoma	ALS2CR12	0.03	0.04	enet	12	0.05	5.4e-10	6.0	6.1	8.5e-10	0.71	0.66	0.34	FALSE
49	The Cancer Genome Atlas	Cervical Squamous Cell Carcinoma	ALS2CR12	0.07	0.03	blup	76	0.05	2.0e-03	5.4	6.1	1.2e-09	0.69	0.08	0.66	FALSE
50	The Cancer Genome Atlas	Cervical Squamous Cell Carcinoma	CASP8	0.09	0.09	lasso	2	0.08	8.6e-05	7.3	-7.3	3.7e-13	-0.87	0.01	0.98	FALSE
51	The Cancer Genome Atlas	Glioblastoma Multiforme	ALS2CR12	0.09	0.04	blup	76	0.04	2.2e-02	6.5	6.3	3.3e-10	0.76	0.03	0.46	FALSE
52	The Cancer Genome Atlas	Head and Neck Squamous Cell Carcinoma	CASP8	0.07	0.06	lasso	3	0.06	1.6e-07	7.2	-7.4	1.9e-13	-0.90	0.01	0.99	FALSE
53	The Cancer Genome Atlas	Kidney Renal Clear Cell Carcinoma	ALS2CR12	0.05	0.03	blup	76	0.05	2.8e-06	-4.5	6.5	6.4e-11	0.80	0.20	0.79	FALSE
54	The Cancer Genome Atlas	Brain Lower Grade Glioma	ALS2CR12	0.11	0.09	blup	76	0.09	1.4e-10	6.0	6.4	1.8e-10	0.71	0.89	0.11	FALSE
55	The Cancer Genome Atlas	Lung Adenocarcinoma	ALS2CR12	0.04	0.04	blup	76	0.04	8.5e-06	7.3	6.4	1.5e-10	0.66	0.01	0.98	FALSE
56	The Cancer Genome Atlas	Lung Adenocarcinoma	CASP8	0.07	0.10	enet	11	0.10	2.3e-11	7.3	-7.1	1.5e-12	-0.86	0.01	0.99	FALSE
57	The Cancer Genome Atlas	Lung Squamous Cell Carcinoma	ALS2CR12	0.04	0.03	lasso	2	0.04	3.9e-05	4.7	5.5	3.4e-08	0.61	0.67	0.28	FALSE
58	The Cancer Genome Atlas	Lung Squamous Cell Carcinoma	CASP8	0.06	0.04	enet	8	0.06	5.1e-07	7.3	-7.3	2.1e-13	-0.90	0.01	0.99	FALSE
59	The Cancer Genome Atlas	Prostate Adenocarcinoma	ALS2CR12	0.06	0.06	enet	11	0.08	2.7e-08	4.6	5.5	3.5e-08	0.78	0.07	0.93	FALSE
60	The Cancer Genome Atlas	Soft Tissue Sarcoma	ALS2CR12	0.06	0.01	blup	76	0.03	4.4e-03	7.2	6.8	7.3e-12	0.88	0.01	0.88	FALSE
61	The Cancer Genome Atlas	Soft Tissue Sarcoma	CASP8	0.09	0.05	enet	12	0.09	7.0e-06	7.3	-5.5	4.1e-08	-0.70	0.03	0.97	FALSE
62	The Cancer Genome Atlas	Thyroid Carcinoma	ALS2CR12	0.11	0.11	lasso	6	0.11	1.3e-10	6.0	6.6	4.3e-11	0.79	0.05	0.95	FALSE